Epigenetics and Genomics LaboratoryGenome Biology and Genetic DiseasesMedia ReleasesNews & EventsResearch
‘Smart’ Plants for Space Travel
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genome Biology and Genetic Diseases, Media Releases, News & Events, ResearchResearchers from Harry Perkins Institute of Medical Research and the University of Western Australia have developed synthetic genetic circuits that can turn plant genes on or off based on the…
Epigenetics and Genomics LaboratoryFundingGenome Biology and Genetic DiseasesLabMedia ReleasesNews & EventsResearch
Perkins researchers granted funds to advance epigenetic research
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Lab, Media Releases, News & Events, ResearchTwo researchers at the Harry Perkins Institute of Medical Research have been awarded separate grants totalling $3.6million in federal government funding to better understand and treat diseases. Perkins CEO, Prof…
Molecular Endocrinology and PharmacologyNews & Events
Biodesign program wins national award for excellence
By Richard Schoonraad | Molecular Endocrinology and Pharmacology, News & EventsA program that provides industry engagement opportunities and training in biomedical design thinking, while giving industry access to research talent has won a national award. iPREP Biodesign, administered by The…
CancerCancerCancer and Cell BiologyGenetic DiseaseGenetic DiseaseGenome Biology and Genetic DiseasesLabNews & EventsOvarian CancerResearchTumours
“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Genetic Disease, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Ovarian Cancer, Research, TumoursPerth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…
Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area
Phase 3 drug trial for rare chronic kidney disease achieves key milestone
By Richard Schoonraad | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research AreaBiopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…
Epigenetics and Genomics LaboratoryGenetic DiseaseMedia ReleasesMusclesNews & EventsRare Disease Genetics and Functional GenomicsResearch
Support needed for doctors offering couples genetic testing
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genetic Disease, Media Releases, Muscles, News & Events, Rare Disease Genetics and Functional Genomics, ResearchAs the number of genetic abnormalities that can be identified in pre and post pregnancy tests reaches the thousands, a national project has been launched to assist doctors as they…
CancerCancerImmunotherapyMelanomaMelanoma DiscoveryMelonomaNews & EventsResearch
World melanoma expert exposes sailor’s skin cancer risk
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Melanoma, Melanoma Discovery, Melonoma, News & Events, ResearchPerth based cancer researcher Professor Jonas Nilsson regularly sees in his laboratory just how damaging sun exposure is to our skin as he investigates ways to treat melanoma, the most…
CancerCancerCancer and Cell BiologyDisease AreaImmunotherapyLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsResearchTumoursxOncofetal Ecosystem
New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
